TAK-733は、強力な、選択的な、ATP-非競争的MEKアロステリック部位阻害剤で、IC50 が 3.2nMです。

5 5 3レビュー 1製品表彰状
価格 在庫  
USD 214 In stock
USD 403 In stock
USD 428 In stock
USD 1222 In stock
USD 3112 In stock

TAK-733 化学構造
分子量: 504.23



Quality Control & MSDS


  • Combination Therapy
  • Compare MEK Inhibitors
  • 研究分野
  • TAK-733のメカニズム



情報 TAK-733は、強力な、選択的な、ATP-非競争的MEKアロステリック部位阻害剤で、IC50 が 3.2nMです。
目標 MEK1
IC50 3.2 nM [1]
In vitro試験 TAK-733 is highly potent and selective MEK allosteric site inhibitor with IC50 of 3.2 nM. TAK-733 shows potent enzymatic and cell activity with an EC50 of 1.9 nM against ERK phosphorylation in cells. [1]
In vivo試験 TAK-733 demonstrates broad antitumor activity in mouse xenograft models of human cancer including models of melanoma, colorectal, NSCLC, pancreatic and breast cancer. TAK-733 is well tolerated with pharmacokinetics and pharmacodynamics that support once-daily oral dosing in humans. [1] TAK-733 shows maximally efficacious doses at once daily orally doses of 10 mg/kg. [2]
臨床試験 A Multicenter, Open-label, Dose-escalation, Phase I Study of TAK-733, an Oral MEK Inhibitor, in Adult Patients With Advanced Nonhematologic Malignancies.

推薦された実験操作 (公開の文献だけ)

動物実験: [2]

動物モデル Human solid tumor xenograft models including NSCLC (NCI H23 [KRAS and LKB1 mutations]), CRC (SW620 [KRAS, APC, p53 mutations]) Pancreatic cancer (Panc 1 and Capan 1 [KRAS mutations] and BxPC-3 [No MAPK mutations]) models in immunocompromised mice.
製剤 Saline
投薬量 10 mg/kg
管理 Orally administrated once daily for 21 days



Download TAK-733 SDF
分子量 504.23


CAS No. 1035555-63-5
保管 2年-20℃
6月-80℃in DMSO
溶解度 (25°C) * In vitro DMSO 101 mg/mL (200 mM)
<1 mg/mL (<1 mM)
エタノール <1 mg/mL (<1 mM)
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
化学名 (R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione


カスタマーレビュー (3)

Click to enlarge
Source Jonas Nilsson, PhD from University of Gothenburg. TAK-733 purchased from Selleck
Method Western blot, cell apoptosis assays
Cell Lines Mouse carcinoma cells
Concentrations 1-1000 nM
Incubation Time 16/40 h
Results (A) whereas apoptosis was induced at 40h. (B) Biological effects of the compounds correlated with effects on phosphorylation of the MEK target ERK. (C) IC50 on S-phase and ERK-posphorylation: TAK-733=1-10 nM, GSK1120212=<1 nM.

Click to enlarge
Source , , Dr.Wang from Southern Medical Hospital . TAK-733 purchased from Selleck
Method Western blot
Cell Lines A549 cells
Concentrations 0-10 uM
Incubation Time 2 h
Results Effect of MEK inhibitor TAK-733 in A549 cells. A549 cells were incubated with increasing concentrations of TAK-733 for 2 h. The cell lysates were harvested and phosphorylation of indicated proteins was determined by Western blotting.

Click to enlarge
Source Dr. Zhang of Tianjin Medical University. TAK-733 purchased from Selleck
Method Western blot
Cell Lines T47D cells
Concentrations 0-10 μM
Incubation Time 3 h
Results Reduction of ERK1/2 phosphorylation in T47D cells treated with TAK-733 was observed.

製品表彰状 (1)



電話番号: +1-832-582-8158 Ext:3月曜日〜金曜日 9:00 AM–5:00 PM (米国中部標準時)


* 必須

Related MEK 阻害剤

  • MEK162 (ARRY-162, ARRY-438162)

    MEK162 (ARRY-162, ARRY-438162) is a potent inhibitor of MEK1/2 with IC50 of 12 nM.Phase 1

  • Sorafenib

    Sorafenib is a multikinase inhibitor of Raf-1, B-Raf and VEGFR-2 with IC50 of 6 nM, 22 nM and 90 nM, respectively.

  • TAK-632

    TAK-632 is a potent pan-Raf inhibitor with IC50 of 8.3 nM and 1.4 nM for B-Raf(wt) and C-Raf, respectively, showing less or no inhibition against other tested kinases.

  • JNK Inhibitor IX

    JNK inhibitor IX is a selective and potent JNK inhibitor with pIC50 of 6.5 and 6.7 for JNK2 and JNK3, respectively.

  • Trametinib (GSK1120212)

    Trametinib (GSK1120212)は、非常に特定で有力なMEK1MEK2 阻害剤で、IC50 がそれぞれ 0.92 nM と 1.8 nMです。


  • Selumetinib (AZD6244)

    Selumetinib (AZD6244) は有効的にMEK1を抑制して、IC50 が14 nMになる.


  • PD0325901

    PD0325901は選択的です、そして、非ATP競争的有糸分裂促進物質はMEK活動のinhibitonのためにプロテインキナーゼ・キナーゼ(MEKまたはMAPKK)MEK阻害剤を起動させました。IC50 が 0.33 nMになる。

  • U0126-EtOH

    U0126-EtOH は化学的に合成されて非常に選択的な阻害剤で、MEK1 とMEK2 に作用すると、 IC50 がそれぞれ0.07 μM と 0.06 μMになる。

  • PD98059

    PD98059は、非競争的MEK</bです> 阻害剤で、IC50 が2 μMです.

    Features:PD98059不会抑制已经被c-Raf磷酸化的 MEK1

  • PD184352 (CI-1040)

    PD184352 (CI-1040)は、ATP非競争MEK1/2阻害剤で、IC50 が 17 nMです。

    Features:First MEK inhibitor to begin clinical development.


Tags: TAK-733を買う | TAK-733供給者 | TAK-733を購入する | TAK-733費用 | TAK-733生産者 | オーダーTAK-733 | TAK-733代理店